Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines
Stopped early
Conditions studied: Measles, Mumps, Rubella, Varicella
In brief
The purpose of this study is to see if the MMR and chickenpox vaccines work as well in premature infants as in children that were carried to full term. A group of children who were carried full-term will be matched for age, sex, and race and will be used for comparison.
Key facts
- Study ID
- NCT00138255
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 32
- Starts
- 2004-06-01
- Expected to finish
- 2005-06-01
- Last updated by the study team
- 2010-08-27
Who can join
Age: any, up to 1. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Premature infant < 29 weeks gestation at birth or term infant >= 37 weeks gestation at birth.
- Postnatal age < 16 months, 0 days.
- Has not yet received MMR or varicella vaccines. (There are no restrictions on the administration of other vaccines at the time of MMR/varicella vaccination.)
- Parental permission.
- Agreement of primary care pediatrician/ health care provider.
- Receives primary pediatric care within an approximate 25-mile radius of the University of Rochester.
- Healthy status at enrollment.
You may not qualify if…
- Known immunodeficiency.
- Systemic corticosteroid therapy at the time of MMR/varicella vaccination.
- Requiring oxygen therapy.
- Clinically significant findings on review of medical history and physical exam determined by the investigator or sub-investigator to be sufficient for exclusion.
- Any condition determined by the investigator that would interfere with the evaluation of the vaccine or be a potential health risk to the subject.
Where it is running
- University of Rochester School of Medicine and Dentistry — Rochester, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.